Congress | NACDS

Pharmacy Urges Decisive Action to Close DIR Fee Loophole, Appreciates Senate Finance Committee’s Initial Bipartisan Movement on Issue “DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”

admin2019-07-25T17:02:08-04:00Categories: Press Release|Tags: Congress, DIR, Medicare, Reimbursement|

“DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”

DIR Fee Relief Urgency Clear at NACDS Board Member D.C. Fly-in

admin2019-07-19T07:46:26-04:00Categories: Article|Tags: Congress, DIR, Reimbursement|

NACDS Board of Directors members met with key members of Congress in Washington, D.C., to convey the urgent need for DIR fee relief.

DIR Fee Relief Leads NACDS RxIMPACT Pharmacy Tours

admin2019-07-18T15:00:47-04:00Categories: Article|Tags: Congress, DIR, RxIMPACT|

Members of Congress were able to grasp firsthand critical pharmacy public policy issues when they toured pharmacies in their home states and congressional districts.

Need for DIR Fee Relief Hits Home for Congress

admin2019-07-11T17:59:17-04:00Categories: Article|Tags: Congress, DIR, Reimbursement, RxIMPACT|

During the Fourth of July congressional recess, members of Congress learned firsthand about key pharmacy issues—particularly about the need for direct and indirect remuneration (DIR) fee relief as part of a drug-pricing legislative package.

105 U.S. Reps., 28 U.S. Senators Urge Trump Administration to Fix Pharmacy DIR Fees Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies

admin2019-06-20T10:17:10-04:00Categories: Press Release|Tags: Congress, DIR, Medicare, Reimbursement|

Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies.

DIR Fee Relief Key in Senate HELP Committee Remarks

admin2019-06-07T12:32:41-04:00Categories: Article|Tags: Congress, DIR, Reimbursement|

NACDS emphasized the need for Congress to address direct and indirect remuneration (DIR) fee relief as it considers solutions to reduce healthcare costs.

Put DIR Fees in Front of Congress

admin2019-05-31T12:46:13-04:00Categories: Article|Tags: Congress, DIR, RxIMPACT|

This week, the Harmons Neighborhood Grocery pharmacy in Riverton, Utah, hosted their member of Congress, Representative Ben McAdams.

NACDS Recommends DIR Reform, Other Measures to Lower Drug Costs

admin2019-05-15T09:05:04-04:00Categories: Article|Tags: Congress, DIR, Drug_Pricing|

NACDS recommended several measures to lower prescription drug prices and improve patient health--including DIR fee relief--to the House Committee on Energy and Commerce Subcommittee on Health.

NACDS Lauds Seven-Day Prescription Bill to Mitigate Opioid Abuse Bill would help prevent addiction and abuse, and help prevent opioids from falling into the wrong hands

admin2019-03-15T12:39:00-04:00Categories: Press Release|Tags: Congress, Drug_Abuse|

The bill - introduced by U.S. Sen. Kirsten Gillibrand (D-NY) and U.S. Sen. Cory Gardner (R-CO) - would help prevent addiction and abuse, and help prevent opioids from falling into the wrong hands.

As HHS’ Azar Testifies, NACDS Urges His DIR Reform Proposals NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement

admin2019-03-14T10:14:53-04:00Categories: Press Release|Tags: CMS, Congress, DIR, HHS, Medicare, Reimbursement|

NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement.

National Association of Chain Drug StoresPharmacies. The face of neighborhood healthcare.